Physician profile
Robert Edward Karol
NPI 1174639520
$3,162.91
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $952 · 2021: $678 · 2022: $1,291.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,290.92 | 2022 | |
| Zimmer Biomet Holdings, INC. | $1,108.84 | 2019-2021 | |
| Keystone Dental INC. | $503.48 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $172.65 | 2020-2021 | |
| Premier Dental Products Company | $35.00 | 2020 | |
| Ultradent Products INC | $25.89 | 2019 | |
| Geistlich Pharma, North America, INC. | $13.48 | 2019 | |
| Straumann USA LLC | $12.65 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Karol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.